This study was designed to examine the interaction in the binding of selective angiotensin II receptor antagonists towards angiotensin II type 1 receptor. The AT 1 antagonists used in this study were valsartan, candesartan and losartan. Wild type AT 1 receptors were transiently expressed in COS-7 cells and the expressed protein was isolated. The binding affinities of agonist and these four AT 1 antagonists were determined towards AT 1 receptors with the help of radioligand binding studies. The binding affinity of candesartan has been found to be maximum having a pKi value of 8.61±0.21 whereas losartan showed lowest binding affinity among the antagonists (pKi=7.17±0.07). Telmisartan also showed high (pKi=8.19±0.04) and valsartan had moderate binding affinity (pKi=7.65±0.12) towards AT 1 receptors. The results of the study suggested that candesartan interacts very strongly with the receptor which is consistent with the maximum number of binding sites of in the chemical structure of candesartan. On the other hand, losartan has lower number of binding sites with the amino acid residues of AT 1 receptor and as a result it showed the minimum affinity towards the receptor.
Introduction
G-protein coupled receptors (GPCRs) form one of the largest protein families, with several hundred members in humans. The Angiotensin II (Ang II) receptors are the members of the G-protein coupled receptor (GPCR) superfamily, which form one of the largest protein families, with several hundred members in human (Venter et al., 2001) . Despite the wide variety of ligands and physiological roles, all these receptors are structurally characterized by seven transmembrane domains. Two subtypes of Ang II receptors have been identified (Whitebread et al., 1989; Chiu et al., 1989) and functionally characterized: Ang II type 1 (AT 1 ) and type 2 (AT 2 ) receptors (Bumpus et al., 1991) . AT 1 receptor mediates virtually all the known physiological actions of Ang II, including vascular contraction, aldosterone secretion, sodium and water retention, neuronal activation, and cardiovascular cell growth and proliferation (De Gasparo et al., 2000; Burnier, 2001) . AT 1 receptor is an important target for drug development, as the abnormalities in its function are linked to hypertension, water-electrolyte imbalance, hyperaldosteronism, cardiac hypertrophy, and heart failure (Peach, 1977) . Ang II receptor blockers (ARBs) are highly selective for AT 1 receptor. In addition to their blood pressure-lowering effects, ARBs have been shown to promote regression of left ventricular hypertrophy and decrease cardiovascular morbidity and mortality in patients with heart failure or hypertensive diabetic nephropathy with proteinuria (De Gasparo et al., 2000) .
Ang II binds to AT 1 receptor and induces cell signaling accompanied by changes in the transmembrane (TM 3-TM 6) conformation (Ghanouni et al., 2001) . AT 1 receptor binds a peptide ligand and does not share significant overall homology with other receptors of the seven-transmembrane domain family. Peptide antagonists have higher affinity toward the AT 1 receptor, suggesting that they bind in a unique conformation to the receptor (Noda et al., 1995) . In this study, we determined the binding affinity of different non-peptide AT 1 antagonists with wild type AT 1 receptors using [ Membrane preparation: Stably transfected COS-7 cells were grown in 10-cm plates. The confluent plates were harvested with ice-cold phosphate buffer saline (PBS), pH 7.4, washed by HBSS with 1.5% 0.5 M EDTA, 0.15% 50 mg/ml PMSF and 0.15% 2 mg/ml aprotinin, and finally suspended in 0.25 M sucrose solution containing 1.5% 0.5 M EDTA, 0.15% 50 mg/ml PMSF and 0.15% 2 mg/ml aprotinin. The cells were then disrupted by Polytron Homogenizer for 10 seconds. The mass was centrifuged at 4 o C for 5 minutes at 1260 g and the supernatant was ultra centrifuged at 4 o C for 20 minutes at 30,000 g. The resulting pellets were suspended in binding assay buffer and used for binding experiments. The protein contents of the membrane concentrations were measured by the method of Lowry et al. (1951) for 1 hr at 25°C. The incubation was terminated by rapid filtration under vacuum through Whatman GF/C filters that had been presoaked in 0.5% polyethyleneimine followed by three times washing with 4 ml ice-cold 50 mM tris HCl (pH 8.0). The radioactivity retained on the filters was measured by liquid scintillation spectrophotometry.
Materials and Methods

Drugs
Data Analysis: Nonlinear regression analyses of saturation and competition binding assay were performed using GraphPad Prism software (San Diego, CA, USA). The results of experiments were expressed as the mean ± S.E.M. In competition binding experiments, the values of inhibition constants (K i ) were calculated by the following equation (Cheng and Prusoff 1973) :
where, the inhibition concentrations (IC 50 ) were determined as the concentrations of ligands that inhibited 
Results and Discussion
Radioligand binding experiments for cloned AT 1 receptor: In saturation experiment, specific binding of [ 3 H]-Angiotensin II was determined using the cloned AT 1 receptor subtype. The affinity constant (K d ) was 509.7 ± 18.5 pM and the receptor density (B max ) for the membrane was 670.7 ± 39.8 fmol/mg protein. Table 1 shows the binding affinities (pK i ) for AT 1 receptor antagonists in which candesartan showed maximum binding affinity towards wild type AT 1 receptor and losartan had the lowest value. Telmisartan also showed high affinity whereas valsartan had moderate affinity towards the receptor.
In saturation binding experiment, the data represent the different level of cell expression of wild type AT 1 receptor. The binding affinity of the drug to receptor depends upon the interaction between the functional group of ligand and the receptor protein. The mechanism of binding of antagonists to human AT 1 receptor is still not well understood. However, some reports have been published showing the important sites of interaction with different antagonists in AT 1 receptor (Miura et al. 2006; Underwood et al. 1994; Verheijen et al. 2000 Verheijen et al. , 2003 . In our previous study we identified the binding sites of nonpeptide Ang II receptor antagonists with AT 1 receptor by molecular modeling (Bhuiyan et al., 2009) . There it was shown that candesartan has a maximum of four binding sites interacting with the receptor. The carboxylate group and the ethoxy group of candesartan play a very important role in binding with the receptor in addition to the biphenyl tetrazole ring. Valsartan and losartan has three and two sites respectively. The results of the competition binding studies thus correspond to the previous findings although the binding affinity of telmisartan was found to be irrespective to binding sites (Figure 1 ). The data shown indicate the mean ± SEM of pK i values and numbers in parentheses indicate the number of experiments. 
Conclusion
In summary, the number of the binding sites of losartan may be smallest of the antagonists of this study, being consistent with the lowest binding affinity of losartan. In addition, candesartan would have another extra hydrogen bond with the receptor. The number of interacting sites is consistent with the higher binding affinity of candesartan than valsartan. As telmisartan also showed high binding affinity towards AT 1 receptor, the carboxylate group may have profound role in binding between the ligand and the receptor. The number of the hydrogen bonds between the ligands and the receptor may thus correspond to the order of the binding affinity of the antagonists.
